Latest Insider Transactions at Healthcare Services Group Inc (HCSG)
This section provides a real-time view of insider transactions for Healthcare Services Group Inc (HCSG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of HEALTHCARE SERVICES GROUP INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of HEALTHCARE SERVICES GROUP INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 31
2022
|
Dino D Ottaviano Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,330
+36.4%
|
$39,610
$17.17 P/Share
|
|
May 31
2022
|
Jude Visconto Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,330
+39.05%
|
$39,610
$17.17 P/Share
|
|
May 31
2022
|
John J Mc Fadden Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,330
+39.05%
|
$39,610
$17.17 P/Share
|
|
Feb 23
2022
|
Theodore Wahl President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,132
-3.54%
|
$172,244
$17.08 P/Share
|
|
Feb 23
2022
|
Theodore Wahl President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
13,573
+4.52%
|
$230,741
$17.08 P/Share
|
|
Jan 05
2022
|
Robert L Frome Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,001
+23.57%
|
$85,017
$17.5 P/Share
|
|
Jan 04
2022
|
Kurt Simmons Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,289
+50.0%
|
$23,202
$18.1 P/Share
|
|
Jan 04
2022
|
Andrew M Brophy Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
81
-19.8%
|
-
|
|
Jan 04
2022
|
Andrew M Brophy Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
166
+17.08%
|
-
|
|
Jan 04
2022
|
Patrick J Orr EVP & Chief Revenue Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,896
-16.95%
|
-
|
|
Jan 04
2022
|
Patrick J Orr EVP & Chief Revenue Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,218
+7.32%
|
-
|
|
Jan 04
2022
|
Andrew Kush EVP & Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,699
-16.34%
|
-
|
|
Jan 04
2022
|
Andrew Kush EVP & Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,602
+7.61%
|
-
|
|
Jan 04
2022
|
Theodore Wahl President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
16,780
-5.79%
|
-
|
|
Jan 04
2022
|
Theodore Wahl President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,525
+2.67%
|
-
|
|
Jan 04
2022
|
John Christopher Shea EVP & Chief Admin. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,770
-13.59%
|
-
|
|
Jan 04
2022
|
John Christopher Shea EVP & Chief Admin. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,832
+6.37%
|
-
|
|
Jan 04
2022
|
Jason J Bundick EVP/Gen. Counsel/Corp. Secty. |
SELL
Payment of exercise price or tax liability
|
Direct |
3,514
-16.15%
|
-
|
|
Jan 04
2022
|
Jason J Bundick EVP/Gen. Counsel/Corp. Secty. |
BUY
Exercise of conversion of derivative security
|
Direct |
6,098
+7.3%
|
-
|
|
Jan 03
2022
|
Andrew M Brophy Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
123
+33.61%
|
-
|
|
Jan 03
2022
|
Patrick J Orr EVP & Chief Revenue Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,289
+13.92%
|
-
|
|
Jan 03
2022
|
Patrick J Orr EVP & Chief Revenue Officer |
BUY
Grant, award, or other acquisition
|
Direct |
889
+11.74%
|
$13,335
$15.12 P/Share
|
|
Jan 03
2022
|
Andrew Kush EVP & Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,819
+14.95%
|
-
|
|
Jan 03
2022
|
Andrew Kush EVP & Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
515
+3.75%
|
$7,725
$15.12 P/Share
|
|
Jan 03
2022
|
Theodore Wahl President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,547
+5.66%
|
-
|
|
Jan 03
2022
|
Theodore Wahl President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
889
+0.36%
|
$13,335
$15.12 P/Share
|
|
Jan 03
2022
|
John Christopher Shea EVP & Chief Admin. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,819
+11.88%
|
-
|
|
Jan 03
2022
|
John Christopher Shea EVP & Chief Admin. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
889
+4.68%
|
$13,335
$15.12 P/Share
|
|
Jan 03
2022
|
Jason J Bundick EVP/Gen. Counsel/Corp. Secty. |
BUY
Exercise of conversion of derivative security
|
Direct |
2,818
+15.25%
|
-
|
|
Nov 23
2021
|
John Briggs Director |
SELL
Open market or private sale
|
Direct |
5,001
-18.89%
|
$90,018
$18.71 P/Share
|
|
Nov 23
2021
|
John Briggs Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,001
+15.89%
|
$85,017
$17.5 P/Share
|
|
Jun 01
2021
|
John J Mc Fadden Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,307
+50.0%
|
$39,210
$30.61 P/Share
|
|
Jun 01
2021
|
Robert L Frome Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,307
+10.44%
|
$39,210
$30.61 P/Share
|
|
Jun 01
2021
|
Diane S Casey Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,307
+50.0%
|
$39,210
$30.61 P/Share
|
|
Jun 01
2021
|
Jude Visconto Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,307
+50.0%
|
$39,210
$30.61 P/Share
|
|
Jun 01
2021
|
Laura K Grant Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,307
+50.0%
|
$39,210
$30.61 P/Share
|
|
Jun 01
2021
|
Dino D Ottaviano Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,307
+42.88%
|
$39,210
$30.61 P/Share
|
|
Jun 01
2021
|
John Briggs Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,307
+5.74%
|
$39,210
$30.61 P/Share
|
|
Jun 01
2021
|
Daniela Castagnino Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,307
+50.0%
|
$39,210
$30.61 P/Share
|
|
Feb 25
2021
|
Theodore Wahl President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,652
-4.95%
|
$354,256
$28.58 P/Share
|
|
Feb 25
2021
|
Theodore Wahl President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
16,950
+6.22%
|
$474,600
$28.58 P/Share
|
|
Jan 04
2021
|
John Christopher Shea EVP & Chief Admin. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,193
-15.7%
|
-
|
|
Jan 04
2021
|
John Christopher Shea EVP & Chief Admin. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,649
+9.96%
|
-
|
|
Jan 04
2021
|
Jason J Bundick EVP/Gen. Counsel/Corp. Secty. |
SELL
Payment of exercise price or tax liability
|
Direct |
3,116
-19.53%
|
-
|
|
Jan 04
2021
|
Jason J Bundick EVP/Gen. Counsel/Corp. Secty. |
BUY
Exercise of conversion of derivative security
|
Direct |
7,419
+12.97%
|
-
|
|
Jan 04
2021
|
Michael E Mc Bryan Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,709
-8.69%
|
-
|
|
Jan 04
2021
|
Michael E Mc Bryan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,344
+5.16%
|
-
|
|
Jan 04
2021
|
Michael E Mc Bryan Director |
BUY
Grant, award, or other acquisition
|
Direct |
503
+1.99%
|
$10,060
$20.67 P/Share
|
|
Jan 04
2021
|
Theodore Wahl President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
14,302
-5.66%
|
-
|
|
Jan 04
2021
|
Theodore Wahl President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
36,048
+3.61%
|
-
|